Lifeblood’s Houston MedTech Event
| March 13th
|
Overview:
Thomas Busby will be moderating a panel at Giovanni Lauricella & Lifeblood‘s MedTech event in Houston on March 13th. This one-day intensive crash course is a must-attend for MedTech CEOs and senior executives looking to gain insights on raising capital, setting strategy, initiating clinical trials, working with a Board, and navigating successful exits via M&A. It’s a fantastic opportunity to connect with industry leaders and deepen your knowledge in the MedTech space. Don’t miss out—register soon as spaces are filling up quickly! |
News
Outcome Capital Named Top Life Sciences Advisory and Strategic Investment Banking Solutions Provider for 2026
Outcome Capital has been named Life Sciences Review’s exclusive recipient of the “Top Life Sciences Advisory and Strategic Investment Banking Solutions 2026” award, recognizing its unique approach to helping life sciences companies move innovations from development to commercialization. The firm combines scientific, clinical, operational, and financial expertise to support emerging and growth-stage companies with fundraising, […]
Read MoreResources
Outcome Capital Life Science Pulse
Outcome Capital Life Science Market Pulse June 2026 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
